BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28424414)

  • 21. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
    Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
    J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer.
    Karabulut S; Kaya Z; Amuran GG; Peker I; Özmen T; Gūllūoḡlu BM; Kaya H; Erzik C; Ōzer A; Akkiprik M
    Breast Dis; 2016; 36(4):123-131. PubMed ID: 27612043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
    Parrella P; Poeta ML; Gallo AP; Prencipe M; Scintu M; Apicella A; Rossiello R; Liguoro G; Seripa D; Gravina C; Rabitti C; Rinaldi M; Nicol T; Tommasi S; Paradiso A; Schittulli F; Altomare V; Fazio VM
    Clin Cancer Res; 2004 Aug; 10(16):5349-54. PubMed ID: 15328171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
    Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
    Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
    Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes.
    Lin IH; Chen DT; Chang YF; Lee YL; Su CH; Cheng C; Tsai YC; Ng SC; Chen HT; Lee MC; Chen HW; Suen SH; Chen YC; Liu TT; Chang CH; Hsu MT
    PLoS One; 2015; 10(2):e0118453. PubMed ID: 25706888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
    Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative expression of rRNA transcripts and 45S rDNA promoter methylation status are dysregulated in tumors in comparison with matched-normal tissues in breast cancer.
    Karahan G; Sayar N; Gozum G; Bozkurt B; Konu O; Yulug IG
    Oncol Rep; 2015 Jun; 33(6):3131-45. PubMed ID: 25962577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
    Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
    Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
    Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
    Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients.
    Fleischer T; Edvardsen H; Solvang HK; Daviaud C; Naume B; Børresen-Dale AL; Kristensen VN; Tost J
    Int J Cancer; 2014 Jun; 134(11):2615-25. PubMed ID: 24395279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression.
    Bhat A; Masood A; Wani KA; Bhat YA; Nissar B; Khan NS; Ganai BA
    Tumour Biol; 2017 Apr; 39(4):1010428317697563. PubMed ID: 28443466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.
    Kwon MS; Kim SJ; Lee SY; Jeong JH; Lee ES; Kang HS
    Oncol Rep; 2006 Jan; 15(1):27-32. PubMed ID: 16328031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RhoBTB2 gene in breast cancer is silenced by promoter methylation.
    Tang W; Wang C; Fu F; Chen Q
    Int J Mol Med; 2014 Mar; 33(3):722-8. PubMed ID: 24356943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.